Prestige Consumer Healthcare Inc
Company Profile
Business description
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige’s key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer’s Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
Contact
660 White Plains Road
TarrytownNY10591
USAT: +1 914 524-6800
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2025
Employees
570
Stocks News & Analysis
stocks
Ask the analyst: Is the market underestimating Bapcor?
stocks
Is our ASX best idea still attractive after shares surge?
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,758.50 | 10.90 | 0.12% |
| CAC 40 | 8,006.22 | 33.19 | 0.42% |
| DAX 40 | 21,911.74 | 124.74 | 0.57% |
| Dow JONES (US) | 44,470.41 | 167.01 | 0.38% |
| FTSE 100 | 8,767.80 | 67.27 | 0.77% |
| HKSE | 21,420.38 | 101.60 | -0.47% |
| NASDAQ | 19,714.27 | 190.87 | 0.98% |
| Nikkei 225 | 38,801.17 | 14.15 | 0.04% |
| NZX 50 Index | 12,896.51 | 20.16 | 0.16% |
| S&P 500 | 6,066.44 | 40.45 | 0.67% |
| S&P/ASX 200 | 8,490.80 | 8.00 | 0.09% |
| SSE Composite Index | 3,311.45 | 10.72 | -0.32% |